4 results
The main objective of this trial is to investigate the efficacy of inhaled molgramostim compared to placebo.
Primary Objective:The primary objective for this study is to evaluate, in treatment-naive subjects with chronic HCV GT-2 or -3 infection:* SVR12 following 24 weeks of treatment with Lambda/RBV and the SVR12 following 24 weeks of treatment with alfa-…
To determine the accuracy of Vasovist® enhanced MRA of the leg with regard to quantitative grading of stenosis (<50%, >=50%) compared to digital subtraction angiography (DSA, standard of reference (SOR))
The main objective of this trial is to investigate safety of long term use of inhaled molgramostim by collecting information on the side effects.